Cargando…

An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffolds

The recent outbreak of the COVID-19 pandemic caused by severe acute respiratory syndrome-Coronavirus-2 (SARS-CoV-2) has shown the necessity for fast and broad drug discovery methods to enable us to react quickly to novel and highly infectious diseases. A well-known SARS-CoV-2 target is the viral mai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schake, Philipp, Dishnica, Klevia, Kaiser, Florian, Leberecht, Christoph, Haupt, V. Joachim, Schroeder, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243268/ https://www.ncbi.nlm.nih.gov/pubmed/37280244 http://dx.doi.org/10.1038/s41598-023-35671-x

Ejemplares similares

Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein
por: Gerdol, Marco, et al.
Publicado: (2022)

Backbone Brackets and Arginine Tweezers delineate Class I and Class II aminoacyl tRNA synthetases
por: Kaiser, Florian, et al.
Publicado: (2018)

The structural basis of the genetic code: amino acid recognition by aminoacyl-tRNA synthetases
por: Kaiser, Florian, et al.
Publicado: (2020)

Impact of Cholesterol on the Stability of Monomeric and Dimeric Forms of the Translocator Protein TSPO: A Molecular Simulation Study
por: Si Chaib, Zeineb, et al.
Publicado: (2020)

Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors
por: Langdon, Sarah R., et al.
Publicado: (2013)

Novel insights into the somatic proteome of Strongyloides stercoralis infective third-stage larvae
por: Dishnica, Klevia, et al.
Publicado: (2023)

Screening-based discovery of drug-like O-GlcNAcase inhibitor scaffolds
por: Dorfmueller, Helge C., et al.
Publicado: (2010)

Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening
por: Abdulla, Maha-Hamadien, et al.
Publicado: (2009)

Identification of Trypanocidal Activity for Known Clinical Compounds Using a New Trypanosoma cruzi Hit-Discovery Screening Cascade
por: De Rycker, Manu, et al.
Publicado: (2016)

Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor
por: Adasme, Melissa F., et al.
Publicado: (2020)

A multiscale model of the regulation of aquaporin 2 recycling
por: Leberecht, Christoph, et al.
Publicado: (2022)

Application of an interpretable classification model on Early Folding Residues during protein folding
por: Bittrich, Sebastian, et al.
Publicado: (2019)

Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery
por: Devine, William, et al.
Publicado: (2015)

Discovery of new non-pyrimidine scaffolds as Plasmodium falciparum DHFR inhibitors by fragment-based screening
por: Hoarau, Marie, et al.
Publicado: (2021)

Evaluating Known Zika Virus NS2B-NS3 Protease Inhibitor Scaffolds via In Silico Screening and Biochemical Assays
por: Santos, Lucianna H., et al.
Publicado: (2023)

« The Higgs Discovery Explained »
por: Traczyk, Piotr
Publicado: (2021)

Discovery of Survivin Inhibitors Part 1: Screening the Harbor Branch Pure Compound Library
por: Guzmán, Esther A., et al.
Publicado: (2021)

An automated single-molecule FRET platform for high-content, multiwell plate screening of biomolecular conformations and dynamics
por: Hartmann, Andreas, et al.
Publicado: (2023)

Discovery of Potential M2 Channel Inhibitors Based on the Amantadine Scaffold via Virtual Screening and Pharmacophore Modeling
por: Tran, Linh, et al.
Publicado: (2011)

Functionalization of the Chalcone Scaffold for the Discovery of Novel Lead Compounds Targeting Fungal Infections
por: Bonvicini, Francesca, et al.
Publicado: (2019)

Pyrrolidine in Drug Discovery: A Versatile Scaffold for Novel Biologically Active Compounds
por: Li Petri, Giovanna, et al.
Publicado: (2021)

Repurposing of neprilysin inhibitor ‘sacubitrilat’ as an anti-cancer drug by modulating epigenetic and apoptotic regulators
por: Kumbhar, Navanath, et al.
Publicado: (2023)

Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors
por: Mamidala, Rajinikanth, et al.
Publicado: (2016)

Known sequence features explain half of all human gene ends
por: Shkurin, Aleksei, et al.
Publicado: (2023)

In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin
por: Khanra, Supriya, et al.
Publicado: (2018)

Discovery of Ligand-Efficient Scaffolds for the Design of Novel Trichomonas vaginalis Uridine Nucleoside Ribohydrolase Inhibitors Using Fragment Screening
por: Auletta, Shannon, et al.
Publicado: (2019)

Structure-Based Scaffold Repurposing toward the Discovery of Novel Cholinesterase Inhibitors
por: Dighe, Satish N., et al.
Publicado: (2020)

A Subset Screen of the Compounds Australia Scaffold Library Identifies 7-Acylaminodibenzoxazepinones as Potent and Selective Hits for Anti-Giardia Drug Discovery
por: Hart, Christopher J. S., et al.
Publicado: (2022)

Corrigendum: Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors
por: Mamidala, Rajinikanth, et al.
Publicado: (2016)

Discovery of novel elongator protein 2 inhibitors by compound library screening using surface plasmon resonance
por: Xu, Chang-Peng, et al.
Publicado: (2019)

Safe passage : the transition from British to American hegemony /
por: Schake, Kori N.
Publicado: (2017)

Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification
por: Ballester, Pedro J., et al.
Publicado: (2012)

To explain the world: the discovery of modern science
por: Weinberg, Steven
Publicado: (2015)

Editorial: Natural compounds as scaffolds for the discovery of new anti-cancer drugs: Focus on terpenoids and flavonoids
por: Sülsen, Valeria P., et al.
Publicado: (2022)

Discovery of new acetylcholinesterase inhibitors for Alzheimer’s disease: virtual screening and in vitro characterisation
por: David, Benoit, et al.
Publicado: (2021)

Automated in vivo compound screening with zebrafish and the discovery and validation of PD 81,723 as a novel angiogenesis inhibitor
por: Mauro, Antonio N., et al.
Publicado: (2022)

Mind the gap: can we explain declining male reproductive health with known antiandrogens?
por: Kortenkamp, Andreas, et al.
Publicado: (2014)

Haplotype-based approach to known MS-associated regions increases the amount of explained risk
por: Khankhanian, Pouya, et al.
Publicado: (2015)

Mosaic Deletions of Known Genes Explain Skeletal Dysplasias With High and Low Bone Mass
por: Muurinen, Mari, et al.
Publicado: (2022)

Retraction of ‘known sequence features can explain half of all human gene ends’
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8hsgguco00s74flocb6cci87in